Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Trial of Cariprazine in Bipolar I Depression
2016-000757-13Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- May 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cariprazine in bipolar I disorder (3 arms), sponsored by Forest Laboratories. Primary endpoint: Change in MADRS total score. Started May 2016; status: completed.
02
Drugs
cariprazine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on 2016-000757-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000757-13.